“That’s enough patients for everyone!”: Local stakeholders’ views on attracting patients into Barbados and Guatemala’s emerging medical tourism sectors by unknown
RESEARCH Open Access
“That’s enough patients for everyone!”:
Local stakeholders’ views on attracting
patients into Barbados and Guatemala’s
emerging medical tourism sectors
Jeremy Snyder1*, Valorie A. Crooks2, Rory Johnston2, Alejandro Cerón3 and Ronald Labonte4
Abstract
Background: Medical tourism has attracted considerable interest within the Latin American and Caribbean (LAC)
region. Governments in the region tout the economic potential of treating foreign patients while several new
private hospitals primarily target international patients. This analysis explores the perspectives of a range of medical
tourism sector stakeholders in two LAC countries, Guatemala and Barbados, which are beginning to develop their
medical tourism sectors. These perspectives provide insights into how beliefs about international patients are
shaping the expanding regional interest in medical tourism.
Methods: Structured around the comparative case study methodology, semi-structured interviews were conducted
with 50 medical tourism stakeholders in each of Guatemala and Barbados (n = 100). To capture a comprehensive
range of perspectives, stakeholders were recruited to represent civil society (n = 5/country), health human resources
(n = 15/country), public health care and tourism sectors (n = 15/country), and private health care and tourism
sectors (n = 15/country). Interviews were transcribed verbatim, coded using a collaborative process of scheme
development, and analyzed thematically following an iterative process of data review.
Results: Many Guatemalan stakeholders identified the Guatemalan-American diaspora as a significant source of
existing international patients. Similarly, Barbadian participants identified their large recreational tourism sector as
creating a ready source of foreign patients with existing ties to the country. While both Barbadian and Guatemalan
medical tourism proponents share a common understanding that intra-regional patients are an existing supply of
international patients that should be further developed, the dominant perception driving interest in medical
tourism is the proximity of the American health care market. In the short term, this supplies a vision of a large
number of Americans lacking adequate health insurance willing to travel for care, while in the long term, the
Affordable Care Act is seen to be an enormous potential driver of future medical tourism as it is believed that
private insurers will seek to control costs by outsourcing care to providers abroad.
Conclusions: Each country has some comparative advantage in medical tourism. Assumptions about a large North
American patient base, however, are not supported by reliable evidence. Pursuing this market could incur costs
borne by patients in their public health systems.
Keywords: Medical tourism, Latin American and Caribbean (LAC) region, Guatemala, Barbados, International
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Introduction
Many governments in the Latin American and Caribbean
(LAC) region are actively promoting their health services
to private international patients. More commonly called
‘medical tourists’, these are patients who travel inter-
nationally with the intention of receiving medical care
paid for out of pocket. Patients have long crossed national
borders to go to nearby countries within the region in
order to access medical care, particularly as several LAC
nations in Central America and the Caribbean consist of
small states that are unable to provide a full range of med-
ical services domestically [1, 2]. More recently, emphasis
has been placed on promoting medical travel from across
the world to the LAC region, with particular emphasis on
attracting ‘customers’ from the United States (US) and
Canada [3, 4].
Well established medical tourism destinations in the
LAC region include Cuba, Costa Rica, and Panama [5].
Hospitals in these established medical tourism destina-
tions have long provided care to patients from through-
out the LAC region, having only relatively recently
expanded their marketing to international patients be-
yond the region [1]. Recent years have seen a number of
other LAC countries express interest in developing med-
ical tourism, most of which are at an early stage of sec-
tor development. For example, in 2014 a 104 bed
hospital focused on performing heart and cardiac surger-
ies for international patients opened in the Cayman
Islands [6]. The Bahamas hosted American investors in
2013 who were interested in developing a controversial
US$200 million hospital that would offer a range of sur-
gical procedures for patients from North America [7].
Belizean physicians and tourism operators recently
formed the Belize Medical Tourism Association and are
actively seeking investment in this sector from the US
[8]. In Jamaica, there are plans to open a US$170 million
50–75 bed facility focusing on cosmetic, bariatric, and
dental services, expanding in future years to a 200 bed
multi-specialty hospital [9]. Colombia is seeking to in-
crease the number of facilities catering primarily to
international patients (currently there are over twenty
providing a range of tertiary services to around 30,000
medical tourists annually), with government incentives
that include generous tax holidays, enhanced English
language training for health workers and efforts to in-
crease the number of medical specialists [10]. The Turks
and Caicos hosts some Canadian orthopedic surgeons
who in recent years have started to bring their patients
there for treatment in order to avoid wait times for care
in Canada [11]. These are but a few specific examples of
types of medical tourism initiatives emerging in the LAC
region. Governments of these countries and private sector
partners must work to establish their ‘brand’ as a viable
medical tourism destination, which requires consideration
of who their desired international patient base is and how
they will compete for attracting these patients, including
compared to others in the LAC region.
On the one hand, medical tourism has the potential to
diversify the economies of LAC destination countries
through recruiting privately-paying international patients
by providing more specialist services than the domestic
market can support alone. These expanded health ser-
vices are thought to help retain both local patients who
currently travel internationally for care as well as the
high numbers of skilled health workers who emigrate for
more professionally rewarding or lucrative posts else-
where [12]. However, it is unclear if these outcomes will
be realized for the many LAC countries competing with
each other to develop medical tourism sectors, particu-
larly when success is predicated on luring what is per-
ceived to be a large and lucrative North American
market to their shores [13]. On the other hand, if the
patient flows hoped for by these countries do not
materialize, there is a danger that considerable time and
resources will have been wasted that could otherwise
have been used within the domestic health system or to
develop other economic opportunities. Given the many
LAC governments and hospitals vying for the same
North American market, it is likely that some, at
least, of these countries will not be successful in their
pursuits.
Here we examine the issue of how local stakeholders
in two LAC countries, Barbados and Guatemala, under-
stand who their target medical tourists are by presenting
a thematic analysis of one hundred purposively sampled
key informant interviews conducted in these sites. As we
show in this paper, the governments and some private
health care providers in both countries are beginning to
compete with other countries in the LAC region to at-
tract international patients. In this novel analysis we
examine the issue of who their target patients are and,
more importantly, local stakeholders’ rationales for seek-
ing (or not seeking) particular patient groups. Several
recently published reviews have established that signifi-
cant knowledge gaps that remain about medical tourism
[14, 15]. We believe that this analysis addresses several
such gaps. First, we provide some of the first empirical
insights about the development of the medical tourism
sector in Guatemala while complementing the few stud-
ies previously conducted in Barbados [1, 3, 16–19], all of
which contribute new first-hand insights to the global
dialogues about the health equity impacts of the medical
tourism industry (e.g., [20, 21]). Second, we provide on-
the-ground insights from some local stakeholder groups
that have rarely been consulted about their perspectives
on medical tourism sector development, such as commu-
nity organizations and other civil society representatives.
Third, and most importantly, we show that destination
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country stakeholders do not view medical tourists as a
homogenous group. Although this might sound logical,
much of the scholarly literature on medical tourism
glosses over such differences, and never has an analysis
explicitly interrogated them nor situated them within the
context of local and regional medical tourism sector
growth. We show throughout this paper that some med-
ical tourists are thought to be more desirable than others
by destination countries, or are thought to be more likely
to travel to particular countries than others, and the basis
for this reasoning.
Background
Guatemala, located on the Central American isthmus and
bordering the Caribbean Sea, is a lower-middle income
LAC region country with a land area of 108,889 km2 and
a population of 15.5 million people [22]. Guatemala has a
small number of highly resourced private hospitals and
what is widely thought to be an under resourced public
health care system. There is a great range in the
quality of care available throughout the country and
most Guatemalans rely on charitable or public hospi-
tals for medical care [23]. Barbados is a small island
state in the Eastern Caribbean. A high-income country, it
is far smaller than Guatemala with only 431 km2 of land
and a population of 285,000 people [22]. Barbados’ health
system provides universal coverage for public medical ser-
vices to citizens, while private clinics and a small hospital
provide faster access to patients with private insurance or
the ability to pay directly [24]. While the health systems of
Barbados and Guatemala contrast with one another in
their organization and capacity, both are at the early stages
of orienting themselves towards exporting their private
health care services to the international market. In the re-
mainder of this section, we provide a brief overview of the
private and public sector activities occurring in each coun-
try that are acting to promote medical tourism.
In order to promote its medical tourism sector, in
2011 Guatemala’s Tourism Commission for Health and
Wellness started undertaking trade missions abroad and
attending national and international trade fairs aimed at
the medical tourism market. These efforts were coupled
with familiarization tours of the Guatemalan private
medical sector for foreign medical tourism brokers, in-
surance agents, and the press. The target market for
these early initiatives were expatriate Guatemalans and
other Latin Americans living in the US, as well as baby
boomers and self-insured businesses in the US without
existing connections to the LAC region [25]. The
Guatemalan Association of Exporters (AGEXPORT)
separately conducted a study of the Guatemalan pri-
vate health care sector compared to LAC regional
competitors in 2013. This study determined that den-
tistry, human reproduction, and ophthalmology were
Guatemala’s most competitive and viable sectors for
medical tourism [26].
The focus of Guatemala’s medical tourism sector de-
velopment is on making better use of existing capacity
rather than building new facilities specifically targeting
high-paying international patients. Medical tourism fa-
cilitation companies aiming to bring American patients
to Guatemala tout the cost savings when compared to
the US and the high quality of care available at some
private hospitals [27–29]. In order to make their facil-
ities more appealing to international patients, some
facilities in Guatemala are seeking Joint Commission
International accreditation and bi-lingual nursing train-
ing opportunities [23]. Medical tourism brokers adver-
tise Guatemala as a medical tourism destination online,
emphasizing its cost-competitiveness and quality to po-
tential clients in North America. AGEXPORT has ac-
tively promoted medical tourism from the US by
attempting to partner with US employers and banks to
facilitate insurance coverage and payments for medical
treatments [23]. However, the distance of Guatemala
from the US when compared to other LAC regional
competitors has been highlighted as a disadvantage
for being able to develop a robust medical tourism
sector [30].
As with Guatemala, Barbados is actively seeking pri-
vate patients from outside the Caribbean. In 2008, the
government of Barbados created a health and wellness
taskforce that intended to develop the medical tourism
sector with an aim toward attracting patients from out-
side of the region. Barbados also hosted conferences
promoting international health and wellness tourism in
2008 and 2010 [24]. A Health and Wellness Taskforce,
formed in 2008 by the Ministry of Health, was tasked
during this period with incentivizing foreign investment
in Barbados’ medical tourism sector. These incentives
include tax exemption for medical equipment imports,
exemption from real estate taxes, and suspension of
costs associated with starting and reorganizing new busi-
nesses. This task force also sought to promote Barbados’
brand as a safe, high quality destination for medical
treatment in North American and the EU. This was
attempted through promotional activities online, trade
missions, referral networks with health care providers,
and promotion of positive news stories on Barbados’
health sector in international media [24].
To date, medical tourism activities largely focus on the
Barbados Fertility Centre, a small reproductive health
clinic that draws on patients from the Caribbean as well
as the US, Canada, and United Kingdom (UK) [3, 31].
This clinic reports a 33 % growth in patients since 2009
despite the economic downturn and drop in traditional
tourism during this time [32]. Barbados has also hosted
several failed attempts at medical tourism, including a
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stem cell clinic and several proposed international hospi-
tals that have not materialized [24]. A proposed new fa-
cility, American World Clinics (AWC), is seeking to
target the North American market on a much larger
scale than that seen with the Barbados Fertility Centre
by building a 50 bed multi-specialty hospital on the site
of a former private hospital [33]. This proposed facility,
financed by American investors, is the result of an active
push into medical tourism by the Barbadian government
which sought bids from international investors to de-
velop the former hospital site to primarily serve medical
tourists [24]. The future of this project is uncertain,
however; originally scheduled to open in 2013, the pro-
ject has been delayed [5].
As outlined above, the medical tourism industry in the
LAC region is at present rapidly developing and volatile.
However, it is not clear if the push to develop this sector,
with its focus on accessing privately paying patients from
the North American market, is the result of a realistic
assessment of the potential of these markets or the out-
come of industry hype and a fear of being left out of the
competition for foreign investment in health services. In
the remainder of this paper we examine what target pa-
tient markets are driving local stakeholder perceptions
of medical tourism’s potential in the LAC region, with a
focus on Barbados and Guatemala, and how these per-
ceived markets are shaping planning and development
of the sector.
Methods
The goal of this qualitative study, guided by comparative
case study methodology [34, 35], is to examine the
health equity impacts of medical tourism in particular
destination countries in the LAC region, with a focus on
identifying negative and positive health system and pol-
icy changes related to public health care, private health
care, health human resources, investment, and domestic
government involvement. This goal emerged in direct
response to the health equity debates and literature that
have extensively outlined the knowledge gaps that exist
regarding the local impacts of medical tourism in destin-
ation countries and the lack of empirical research
available to support the various positions taken by stake-
holders in these debates [20, 36–38]. The analysis pre-
sented in this article contributes to achieving our overall
study goal by exploring the ways in which emerging
medical tourism destinations – using the cases of
Barbados and Guatemala, both of which have nascent
medical tourism sectors with strategic plans for en-
hancement - envision this sector unfolding and who the
likely international patient inflows will be, wherein the
composition of these inflows directly impacts the types
of local transformations that are needed in order to at-
tract these patient markets.
Recruitment
Following receipt of ethics approval, we sought to pur-
posefully recruit 50 key informant interviewees in each
of Barbados and Guatemala. In order to capture both
breadth and depth of perspective we sought to identify
key informants who represented specific sectors, and
looked to speak with five civil society representatives
(e.g., non-governmental organizations, local chapters of
international organizations, community groups, media),
15 health human resources representatives (e.g., health
workers, medical education professionals, health worker
union representatives), 15 government or public health
care/tourism sector representatives (e.g., employees of
government ministries, hospital and health system admin-
istrators, tourism officials, investment sector representa-
tives), and 15 private health care/tourism representatives
(e.g., tourism consultants, owners/administrators of pri-
vate health care clinics, private investment experts, inves-
tors) in each country. Note that in this article we do not
provide a more detailed breakdown of participants by job
type or sector because of the high risk for identification.
Potential participants were identified simultaneously using
multiple channels: (1) searching media coverage for
names of key individuals; (2) reviewing industry re-
ports; (3) speaking with members of our professional
networks in each country; (4) identifying specific offices/
organizations of interest; and (5) asking participants to
share information about the study with others in their net-
works who might be interested in participating.
After potential participants were identified an e-mail
containing information about the details of the interview
and study was sent along with a request to participate.
All potential participants were invited to take part in the
study because of their professional and practical know-
ledge, and in some cases this meant speaking to people
who were aware of issues highly relevant to medical
tourism but had no detailed knowledge about medical
tourism. Because of this, these initial e-mails were tai-
lored to each individual, explaining why his/her perspec-
tive was particularly useful to the study. In some cases
this initial contact was made by phone or in person.
Those interested in participating in the study were asked
to reply by e-mail or phone to express this interest, after
which an interview was scheduled at a time and location
of the participant’s preference. In instances where inter-
views were scheduled far in advanced, reminder mes-
sages were sent to confirm the time and location. In
some cases interviews were scheduled by phone in order
to accommodate availability or travel schedules.
Data collection
Interviews in Barbados were conducted in English
throughout the country between May, 2013 and February,
2014 by a team of two researchers and two highly trained
Snyder et al. Globalization and Health  (2016) 12:60 Page 4 of 13
research assistants. Interviews in Guatemala were con-
ducted in Spanish in Guatemala City and Antigua between
June and December, 2013 by a team of two highly trained
research assistants. Interviews typically lasted between 45
and 90 min after informed consent was achieved and were
most commonly conducted one-on-one, though in some
instances group interviews were scheduled based on par-
ticipants’ preferences.
Interview questions were developed following an ex-
tensive review of the literature about the health equity
impacts of medical tourism [36], the development of
highly detailed background reports about the develop-
ment of the medical tourism sectors in Barbados and
Guatemala [23, 24], and a review of insights gleaned
from our earlier pilot research in Barbados [16, 18, 19].
Interviews in both countries were conducted using a sin-
gle guide that was organized around a set of common
questions asked of all interviewees and groupings of tai-
lored questions that were asked according to partici-
pants’ expertise. The common questions probed overall
knowledge of medical tourism and local health and
health system challenges and opportunities as well as
participants’ professional backgrounds. Tailored ques-
tions explored the domains of health human resources
(e.g., What changes, if any, have been implemented in
health worker education programs specifically in re-
sponse to the development of medical tourism here?);
domestic government involvement (e.g., What responsi-
bilities does the government hold towards the develop-
ment of the medical tourism sector here and to medical
tourism facilities?); public health care (e.g., Are you
aware of any ways in which existing public health care
facilities are interested in expanding their services to
treat medical tourists?); private health care (e.g., Are pri-
vate clinics or hospitals organizing, advocating, or lobby-
ing to alter public policy to support or promote medical
tourism here?); and foreign investment (e.g., What bar-
riers to private investment in health services exist here?
And are there any that are particularly imposing to for-
eign investors?).
Data analysis
Interviews were recorded digitally. Those conducted in
English were transcribed verbatim. Those conducted in
Spanish were simultaneously transcribed and translated
by a group with possessing the necessary language skills.
Upon completion of data collection, a group of the lead
investigators independently reviewed selected transcripts
in order to identify emergent themes in preparation for
thematic analysis, a technique that involves categorizing
data into themes (units identified from patterns in the
dataset) and contrasting these themes against both the
study objectives and existing literature in order to glean
new insights [39]. Following this, a meeting was held to
discuss coding scheme development, emergent themes,
and analyses worthy of being pursued. After this meeting
one investigator drafted a proposed coding scheme that
inductively and deductively captured the themes and
analyses identified in the meeting. Feedback on the
scheme was then sought from the lead investigator in
order to ensure it adequately captured what the team
had agreed to examine. Next, the 100 transcripts were
uploaded into NVivo in preparation for coding, after
which the investigator who devised the scheme and a re-
search assistant familiar with the study each coded the
same 5 transcripts in order to assess the integrity of the
scheme. Following this, and with the input of the lead
investigator, the coding scheme was revised in order to
ensure more consistent interpretation of each code and
reduce redundancy. The full dataset was then coded by a
single investigator in order to enhance consistency and
overall rigour.
The themes reported on in the current analysis were
identified through a collaborative, iterative process. After
the 100 interviews were coded, the coded data central to
this analysis were extracted and reviewed in full by the
lead author. Extracts that best characterized the agreed
upon themes were compiled and shared among the team
so as to ensure consensus on the scope and scale of their
interpretation and to contrast emerging issues against
what is known in the existing literature. Throughout the
findings section we incorporate direct quotes selected
from these same extracts in order to allow the partici-
pants’ voices to speak.
Results
Participants in both Barbados and Guatemala identified
two broad groups of patients that are being targeted in
developing their medical tourism sectors. The first of
these are international patient groups who are readily
accessible because of their established inflows into the
countries, including members of the Guatemalan dias-
pora, repeat visitors to Barbados, and LAC regional pa-
tients. Each country is also planning to seek out new
traveler inflows as international patients, envisioned as
being drawn largely from continental North American
and, to a lesser extent, European patients with no exist-
ing ties to the region. In this section we examine partici-
pants’ consideration of each broad inflow, articulating
their rationales for seeking particular groups within
these inflows and their thoughts regarding the viability
of treating such patients as their local medical tourism
sectors develop.
Targeting established inflows as future medical tourists:
Guatemala’s diaspora
Guatemalan participants flagged the Guatemalan dias-
pora as an important existing source of international
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patients for private health providers, this being an inflow
that many thought should be targeted for expansion as
the country’s medical tourism sector grows. One partici-
pant described this group as coming “from up north to
visit their family. Once they are here they take advantage
of the opportunity and seek medical services.” Although
one participant indicated cases of these individuals trav-
eling three times a year for regular medical and dental
check-ups, it was more commonly suggested that such
patients could be encouraged to seek such routine
medical care once a year. Existing Guatemalan dias-
pora patients were cited as coming from neighbouring
countries in the LAC region as well as the US,
Canada, and Italy. Some participants expressed reser-
vations about the desirability of diaspora patients in
the medical tourism sector as they are seen to have a
less positive economic impact on Guatemala than
other patients due to their roots in the country:
“What happens is that if you bring a Guatemalan
that lives over there [abroad], they will come and stay
at a family member’s house, and will eat there. If you
bring an American or anyone from anywhere, they
will stay at the hotel, use the taxi, he will go to buy
at Antigua [a holiday town], will eat at restaurants.”
For this reason, it was felt, medical tourism operators
should not be satisfied solely with the diasporic mar-
ket, but should nonetheless seek to increase this
existing patient inflow.
Members of the Guatemalan diaspora were thought
to be motivated to access care in the country while
abroad due to cost savings as “the United States is
too expensive.” Wait times for care were also cited as
a motivation for traveling to Guatemala as “back in
Italy, [you] make an appointment and [you] get it six
months later.” Aside from the costs and wait times
that would encourage such individuals to continue to
access private medical care in Guatemala, the Guatemalan
diaspora was also seen as a desirable group of current
and future medical tourists “because [the patient]
knows that doctors are good and he will have a good
treatment.” Whereas many participants raised con-
cerns that actual and perceived violence in Guatemala
would dissuade potential medical tourists not familiar
with the country, “if your base population … is made
up by Guatemalans who are residents of the US, you
don’t have to convince them of coming here, because
of the violence in the country and etc. They already
travel to Guatemala!” It was pointed out that success-
fully recruiting and treating members of the Guatemalan
diaspora for medical care could ultimately, and quite stra-
tegically, lead to the development of new patient inflows
as they could spread the word about the high quality of
care in Guatemala, thereby encouraging others not of
Guatemalan descent.
Targeting established inflows as future medical tourists:
Barbados’ recreational tourists
While the medical tourism stakeholders we spoke with
in Barbados did not raise emigrant Barbadians as a po-
tential market for the country’s nascent medical tourism
sector, they did see regular visitors to Barbados as an
easily accessible target market. Barbados’ status as a des-
tination for cruise ships was noted as creating the poten-
tial for a larger patient market. If the workers and
possibly passengers from these ships could be enticed to
access Barbados’ private medical facilities, “it could be a
key thing for us.” Another group of regular visitors to
the country that participants thought were a desirable
potential medical tourism inflow were visitors who rou-
tinely stayed for long periods at a time, up to two to
three months per year, many of whom own or rent long-
stay vacation properties. This group of tourists were
thought to be “unique” to Barbados, giving it an advan-
tage over other countries. Short-stay repeat visitors were
viewed as an important existing and future medical tour-
ism market as well, including “people who’ve been in
Barbados and have come to Barbados for the last twenty
years and keep coming.”
As per participants’ understandings, Barbados’ existing
base of recreational tourists were being reframed as a
readily accessible inflow of future medical tourists. The
appeal of these recreational tourists as potential medical
tourists was found in the fact that they were already vis-
iting Barbados and therefore struck stakeholders as a
realistic and achievable patient base. Whereas other
types of medical tourists must be encouraged to visit
Barbados in the first place, this group of potential med-
ical tourists were already largely familiar with the island.
As one participant put it, they were an “easy win for
medical tourism.”
Targeting established inflows as future medical tourists:
regional LAC patients
Stakeholders from both countries viewed privately pay-
ing patients from around the LAC region as an import-
ant part of existing revenue in the private health care
sector and also an important part of an expanded med-
ical tourism sector. For example, a Barbadian participant
stated that “there’s three and half million people around
the Caribbean who want that kind of care …across the
Caribbean [the] patients who travel here is immense.”
Others described the LAC region as “a huge market” or
a “key market”. Many participants from both countries
were quick to point out that Barbados and Guatemala
alike would compete for these patients against other
countries in the LAC region and so would need to be
strategic in expanding upon this existing patient inflow.
Further to this, the stakeholders we spoke with cited the
comparatively high prices for private health care in
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Barbados as a barrier to further serving this highly desir-
able patient group.
Two reasons were most commonly provided as to why
people from elsewhere in the LAC region would travel
to either Barbados or Guatemala, and these same rea-
sons were shared by participants from both countries.
The first is to access better quality of care than is avail-
able at home. A participant involved in planning a pri-
vate medical facility in Barbados spoke of the country’s
potential to serve as a “high quality option for regional
health care” because it “historically has had a reputation
regionally for better health care” than many of its
neighbouring countries. Some interviewees stated that
Guatemala had superior quality of medical services in
all areas compared with neighboring areas such as El
Salvador and Southern Mexico, while others discussed
its competitive advantage in certain sub-disciplines.
The second reason given for intra-regional medical
travel by LAC regional patients was to access care
not available at home. Guatemala, for example, was
cited as having “more and better specialists than in
their own countries” and people from the region “have
faith in the Guatemalan physicians.” A Barbadian
stakeholder reported that in some countries in the
Eastern Caribbean, residents have “no choice [for care]
and therefore they came here.”
Targeting New inflows as future medical tourists:
un/under-insured americans
Participants from both countries spoke of the perceived
potential of attracting un- or under-insured American
patients to their countries as a way to expand their med-
ical tourism sectors. The largely private nature of the US
health system was seen as creating a pool of potential
customers as “there are 50 million uninsured Americans.
If you can’t pay for insurance, you cannot pay for a med-
ical service in the States.” Many participants discussed
projections for potential US patients that were extremely
optimistic and based on the country’s relatively large and
aging population. For example, a Guatemalan participant
referred to a report created by the Deloitte consultancy
[40] that is widely cited throughout the global medical
tourism industry, explaining “that’s been fundamental
for all of us in Guatemala” in understanding the medical
tourism market in the US. This report was interpreted
as claiming that at least 9 million people would soon be
traveling from the US for medical care each year. Even
under this “pessimistic” calculation, one participant
exclaimed that “that’s enough patients for everyone!”
Such comments were echoed by Barbadian participants,
one of whom said that the planned AWC facility was
“the biggest thing for Barbados” in terms of attracting
this inflow. Changes to the US health system through
the Affordable Care Act (ACA) were viewed as a factor
participants thought would push patients out of the US
and into their medical tourism sectors, with some sug-
gesting that Americans remaining uninsured may opt for
care abroad while those who are under insured may find
care abroad more affordable than domestic options de-
pending on the costs of their co-payments.
Within both countries, there was a firm belief that US
patients can be attracted abroad on the basis of price
compared to that of care available domestically. One
Guatemalan participant suggested cost savings in
Guatemala up to 75 % off US prices for particular proce-
dures. Similarly, patients from the US would be drawn
by the lower costs of care in Barbados, where the
“cheaper version” of the same medical procedures could
be accessed for “a quarter” of the price. Retirees from
the US were seen as an additional growth market in
Barbados as medical care there was understood to be
less expensive than that in the US. Participants also dis-
cussed the potential of coupling low prices with insur-
ance reimbursements for American customers, including
“some kind of a formal working agreement” with US in-
surance companies. In this way, American patients
would be able to travel to Guatemala and Barbados for
care, with insurance companies subsidizing or paying
fully. Offering such arrangements was viewed to be a
way to attract greater inflows of (under) insured American
patients. Some Guatemalan participants were wary of
the viability of establishing this particular inflow,
though, suggesting that the country’s high rates of
violence would lessen its attractiveness to American
patients being given multiple international care op-
tions by their insurers: “if I was an American, and I
was offered to come to Guatemala, I wouldn’t really
like to come here. Maybe the price would be tempt-
ing… but violence is so terrible here.”
Targeting New inflows as future medical tourists:
North Americans seeking more accessible care
Regardless of patients’ insurance status at home, it was
recognized by participants in both Barbados and
Guatemala that their medical tourism inflows would
grow by offering care that is more accessible, either cost
wise or timeliness wise, to Canadian and American pa-
tients alike. For attracting inflows of Canadian patients,
it was recognized that the price of services mattered but
also the speed at which they could be accessed. Due to
the public nature of the Canadian health system, these
patients were commonly perceived as facing wait times
for their care that could be overcome by traveling to
Guatemala or Barbados. As one Guatemalan participant
noted, in Canada “the problem is not the lack of services
but the fact that services are over saturated so in order
to fix someone’s knee problem in a surgery, it would take
over two years to get it scheduled.” More generally,
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participants from both countries widely acknowledged
that there are people in both Canada and the US who
are looking abroad to access care to avoid long wait
times or high costs at home and that attracting such pa-
tients into their medical tourism markets was highly
desirable.
The view that Barbados and Guatemala could compete
for North American patients seeking more accessible
care on the basis of cost specifically, rather than those
seeking care that is timelier, was thrown into doubt
by some participants. Several Barbadians identified
Barbados as having a relatively high cost of care, even
when compared with the US. While medical care in
Guatemala was generally thought to be considerably
less expensive than that in the US and Canada, it was
noted that there are countries elsewhere in the LAC
region with even lower costs, thus placing Guatemala
at a competitive disadvantage. A participant argued
that “we shouldn’t waste our time in going to the US
to promote and sell our packages – even if American
Airlines gives us free tickets – because we are more
expensive than the rest of the region and no one will
want to come.” The distance of both Guatemala and
Barbados from Canada and the US was seen as prob-
lematic to capturing this inflow as well. One partici-
pant expressed doubt about Barbados’ potential in
recruiting such patients, saying “I don’t see anyone
flying from States or Canada to come to Barbados for
treatment.” The lack of English language competency
in Guatemala was seen as “the biggest barrier” to
accessing this inflow for the country.
Targeting New inflows as future medical tourists:
North Americans seeking procedures not available
at home
Participants in both Guatemala and Barbados widely
thought that patients from the US and Canada in par-
ticular would be motivated to travel abroad for care not
available domestically, such as experimental procedures
and procedures still undergoing approval by the US
Food & Drug Administration (FDA) or other regulators.
As a result, it was felt that the growing medical tourism
sectors in these countries could capitalize on such de-
mand. As these countries are not limited by US or
Canadian regulators in what treatments they can offer,
they can use their presence outside of these legal systems
as a competitive advantage, providing North American pa-
tients with a reason to travel abroad for care.
Stakeholders thought North American patients might
be motivated to travel abroad to access these experimen-
tal treatments out of a sense that conventional treat-
ments are not likely to be as successful, because all
conventional treatments have been exhausted, or be-
cause of a sense that one’s health is deteriorating while
the patient waits to access new treatments domestically.
One Guatemalan participant noted that these factors are
highly motivating for patients and that “there is a sense
of urgency in the search of this [stem cell] treatment” in
particular. The availability of procedures not approved
in Canada and the US was seen as a draw for Barbados
as well, as in the past Barbados had offered “certain
orthopaedic procedures that were not licensed to be car-
ried out in America.” Offering unapproved interventions
was seen as a potentially lucrative market for both coun-
tries. As a Guatemalan stakeholder described it, “people
are more committed and…due to its cost they leave a
considerable profit.” While North American regulators
will grant approval for some of these treatments offered
abroad, the stakeholders we spoke with indicated that
they could adapt to these changes, offering new treat-
ments as they are developed.
Discussion
Participants in Barbados and Guatemala identified nu-
merous comparative advantages and regional patient
markets that were thought to provide for success in the
medical tourism market. Each country currently receives
a small number of LAC regional patients as customers
for their existing private medical sectors. These regional
markets are different in each case, with Guatemala draw-
ing on Spanish-speaking countries in Central America,
Southern Mexico, and the Western Caribbean and
Barbados drawing from English-speaking countries in
the Eastern Caribbean. While each country must com-
pete with other proximal nations for these patients, the
diversity and size of the LAC region allows for sub-
regional competition and specialization in how countries
market themselves to medical tourists. Moreover, the
large size of the Guatemalan diaspora provides another
market that Guatemala has privileged access to over
other countries in the region. This large diaspora was,
according to participants, an important customer base
that allows Guatemala to overcome considerable repu-
tational problems, especially around violence in the
country. While Barbados has a smaller and, according
to our participants, less important diaspora to draw
on for customers, its positive international reputation
as a safe tourism destination, existing tourism inflows,
and English-speaking population give it preferred ac-
cess to specific markets within the region and in
North America as well. Importantly, stakeholders did
not see all of these markets in terms of ‘medical
tourism’, particularly in the case of diaspora and re-
gional patients. The label of ‘medical tourist’ was
most consistently applied to non-readily accessible pa-
tients whereas more readily accessible patients were
more generally seen simply as internationally-based
patients seeking private care.
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Medical tourism dreams and reality
There is a danger that these countries’ interests in
expanding their medical tourism sectors and gaining
greater exposure in the North American market are un-
likely to be as successful as their participation in LAC
regional and diaspora markets. Of particular concern are
the expectations and factual claims raised by some of
the stakeholders we interviewed. For example, one
Guatemalan stakeholder based their expectations of be-
ing able to enhance inflows of diaspora patients on there
being 1.8 million Guatemalans in California alone and “a
lot of Guatemalans” in Canada. In reality, in 2010 there
were 332,737 persons of Guatemalan origin in California
[41], 1.l million in the US overall [42], and 16,150
Guatemalan immigrants living in Canada in 2006 [43].
While these numbers point to a significant Guatemalan
population in the US at least, they are far below this
stakeholder’s estimates. Similarly the 2008 Deloitte con-
sultancy report [40] referenced as being “fundamental to
all of us in Guatemala” in reporting that “9 million”
Americans would be going abroad for medical tourism
was itself heavily revised downward in 2009 to 1.6 mil-
lion medical tourists estimated for 2012 [44]. While
stakeholders felt that the ACA and US employer insur-
ance would create new flows of patients from the US,
the updated Deloitte report indicates that the effects of
the ACA on employer benefits and health insurance are
“uncertain” and no updated report has been developed
since the passage of the ACA [44]. Beliefs about wait
times for care driving Canadian patient flows were simi-
larly unrealistic. While one stakeholder expressed that
Canadians must wait “over 2 years” to receive knee sur-
gery, in reality half of Canadians referred for such proce-
dures receive this care in 182 days and 90% within
258 days [45]. Importantly, these optimistic views were
not universally held, with some stakeholders in both
Guatemala and Barbados doubting that they would be
cost competitive with established LAC regional medical
tourism exporters, including Mexico (which is closer to
the US) and Costa Rica (which is considered safer than
Guatemala).
The extremely optimistic estimates of international pa-
tient flows by many of the stakeholders we spoke with
may be the result of optimism following their decision
to diversify their tourism markets or a failure to fully in-
form themselves about the reality of medical tourism.
External actors are also certainly to blame for this poten-
tially unrealistic view of the medical tourism market as
well [18]. The aforementioned Deloitte consultancy re-
port, which was consistently misread in favor of medical
tourism development by the stakeholders we spoke with,
has itself been criticized for presenting an overly opti-
mistic view of future sector growth [46]. Industry mem-
bers have made a habit of visiting LAC countries to
promote investment in the medical tourism sector as
well. For example, the Medical Tourism Association, an
industry group that promotes and facilitates sector de-
velopment, has held meetings promoting medical tour-
ism development in Antigua [47], Barbados [48], Guyana
[49], Puerto Rico [50], St. Lucia [51], and other countries
in the region in recent years. Many of these and other
LAC countries also regularly attend Medical Tourism
Association sponsored events such as the World Medical
Tourism and Global Healthcare Congress held annually in
the US [52]. Non-industry groups have actively promoted
the medical tourism sector in the LAC region as well. For
example, the Caribbean Export Development Agency
(CEDA) and Canadian Trade Facilitation Office hosted a
regional meeting in Barbados in 2008 aimed at increasing
health sector exports to Canada [24, 53]. CEDA continues
to be active in promoting the health and wellness sector
in the Caribbean by developing strategy documents for
this related sector [54]. Importantly, some stakeholders
noted that their countries were not clearly cost competi-
tive with other, established medical tourism destinations
in the region and doubted that patients would flock to
these countries in the numbers estimated by other stake-
holders. It is not clear how well these dissenting voices are
being heard by local policy makers, however, given that
each country continues to proceed with plans for promot-
ing their domestic medical tourism sectors.
The costs of pursuing the medical tourism dream
Given that some stakeholders with whom we spoke sys-
tematically overestimated the likely medical tourism
flows from North America and misinterpreted or relied
on outdated versions of industry reports, there is real
cause for concern that the expectations driving develop-
ment of the medical tourism industry in these countries
will not match the reality of future patient flows, and es-
pecially the new inflows they seek to develop. Develop-
ing a medical tourism sector creates opportunity costs
for these countries, taking time and resources away from
government ministries and medical professionals who
are drawn into planning, regulation, and facilitation of
this sector [16, 55]. These groups have finite resources,
and time spent promoting and planning for the develop-
ment of the medical tourism sector necessarily means
time not put to addressing pressing local health needs.
Development deals for medical tourism facilities also
often include land lease deals, redirecting resources into
this sector that might have been put to other purposes.
For example, Barbados agreed to lease a former public
hospital site to the AWC developers for up to 50 years,
meaning that this site could not be re-developed for
local or non-medical use [56].
Development of the medical tourism sector creates
costs and vulnerabilities in absolute terms as well.
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Though not explored in this analysis, many of the stake-
holders we spoke with discussed a push into seeking
international accreditation in order to attract inter-
national patients. Such accreditation is expensive and
time consuming [21, 57], and if international patients do
not come in numbers justifying these expenses, then
both public and private medical providers will lose out
on recouping such investment. Given high levels of com-
petition throughout the LAC region for investment in
medical tourism, developers may seek concessions from
countries that include changes to malpractice laws,
health worker licensure, and duties on imported medical
supplies and equipment that may disadvantage local
medical providers [3, 16, 21]. In the case of Barbados,
AWC has responded to the global economic downturn
by demanding loan guarantees from Barbados while sim-
ultaneously exploring alternative developments in other
Caribbean countries [58]. Should these and other devel-
opments founder due to overly optimistic estimates of
inflows of international patients (particularly Americans),
destination countries such as Guatemala and Barbados
will be left with these potentially enormous costs and little
to show for them.
Responsibility for promoting the medical tourism dream
Given the potential costs of pursuing medical tourism
development, there is an important question of whether
industry groups should be actively promoting the
medical tourism sector in the LAC region. It is not sur-
prising that these groups are actively encouraging devel-
opment of the medical tourism sector across the region
as they stand to gain financially from doing so, either by
offering training, certification, and marketing services to
governments [59] or as a way of promoting their con-
sulting businesses. However, if their success relies on
intentionally or even negligently overestimating the
likely North American patient flows to LAC destina-
tions, then these efforts are morally problematic. More-
over, if industry groups such as the Medical Tourism
Association make similar pitches of the promise of med-
ical tourism to countries throughout the region, then
they should be held morally accountable if, in competing
for this same group of customers, many of these coun-
tries find themselves losers in the regional race for suc-
cess in the medical tourism market.
Also troubling are efforts by non-industry groups such
as CEDA and the Canadian Trade Facilitation Office to
encourage medical tourism development in the LAC re-
gion. Whereas the mission of groups like these is to pro-
mote trade in the region, if patient flows do not match
the high expectations of the stakeholders we spoke with,
there is a danger that these groups will merely encour-
age unsustainable levels of investment and oversatura-
tion of the private medical market. These actions, rather
than promoting new avenues for economic development,
could instead hinder the provision of health services
within these countries if these countries divert attention
from providing domestic health services to promoting
private care for international patients and direct re-
sources into promoting this industry and attracting for-
eign direct investment.
Grounding the medical tourism dream in reality
Despite the dangers posed to Barbados and Guatemala
of pursuing a potentially unrealistic flow of patients from
the US, Canada, and other markets, these countries do
have the potential to expand their medical tourism mar-
kets. More clearly promising medical tourism markets
exist for Barbados and Guatemala in areas where these
countries have a competitive advantage over other LAC
competitors. For Barbados, existing flows of recreational
tourists offer a source of potential patients that could be
expanded on. In Guatemala, the large diaspora popula-
tion abroad is also worth attempting to develop as a pa-
tient base. Both countries also have bases of regional
patients and can provide treatments unapproved in
North America, though regional competition for patients
in both of these areas is great and this market introduces
new risks including reputational harms if these treat-
ments are not well regulated and are taken advantage of
by fraudulent service providers [60]. These expansion ef-
forts, if pursued, should be grounded in careful, inde-
pendent research of market potential rather than the
potentially overly optimistic boosterism of those with an
interest in promoting this sector.
Other LAC countries face similar pressures to invest
in the medical tourism market and challenges in suc-
cessfully doing so [1, 3]. As this study has shown, the
perceived opportunities for successful medical tourism
expansion differ between LAC countries. Similarly, pres-
sures on medical tourism expansion and the expecta-
tions for where future medical tourism customers will
flow from differ between different countries based on
their geography, culture, and history. Therefore, add-
itional research is needed into the past development of
and future plans for the medical tourism sectors in all
LAC countries. This research will be crucial to helping
to reign in the medical tourism dream, promoted by in-
dustry and non-industry groups alike, in these countries
based on likely future patient flows. Moreover, a better
understanding of the context of specific LAC countries
will make regional cooperation possible, ensuring that
these countries are not simply undercutting one another
in pursuit of the same customer base. This research is
the only way to ensure that pursuit of the medical tour-
ism dream in LAC countries does not result in signifi-
cant negative consequences should this dream not be
realized.
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Conclusion
Barbados and Guatemala each have relied on patients
from neighbouring LAC countries to support their nas-
cent medical tourism sectors. Each has also found a
competitive advantage in this sector as well, with
Barbados taking advantage of its positive reputation as a
tourist destination and English speaking population and
Guatemala drawing on its large diaspora population.
These countries, along with many others in the region,
are also seeking to expand their medical tourism sectors
by attracting new patient inflows from the US and
Canadian markets. Success in these markets is uncertain
as the expectations of patient flows expressed by the 100
stakeholders we interviewed for this analysis were often
not backed by the reality of the US and Canadian med-
ical tourist patient markets.
There is a danger, then, that the medical tourism ‘gold
rush’ in the LAC region will create substantial costs to
those countries that invest in the development of this
sector if expected patient flows do not materialize. Al-
most certainly some LAC countries will benefit from de-
velopment of the medical tourism sector. Rather than
competing with one another for the same group of pa-
tients and by using the same marketing plan, the differ-
ences between and comparative advantages of these
countries should be emphasized [13]. While there is no
way to ensure widespread benefits across the LAC re-
gion from developing the medical tourism sector, we be-
lieve these countries would benefit from cooperation
with one another and strategic planning around
specialization and targeting of sub-populations of pa-
tients. While cooperation of this kind is extremely diffi-
cult to achieve, without it the danger is that these
countries will each continue to dream about attracting
the same new international patient inflows, not realizing
that this dream may not be grounded in reality.
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